Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell Transplantation: N. Farhadfar et al

Nosha Farhadfar, Ajoy Dias, Tao Wang, Caitrin Fretham, Saurabh Chhabra, Hemant S. Murthy, Larisa Broglie, Anita D'Souza, Shahinaz M. Gadalla, Robert Peter Gale, Shahrukh Hashmi, A. Samer Al-Homsi, Gerhard C. Hildebrandt, Peiman Hematti, David Rizzieri, Lynette Chee, Hillard M. Lazarus, Christopher Bredeson, Edgar A. Jaimes, Amer BeitinjanehAsad Bashey, Tim Prestidge, Maxwell M. Krem, David I. Marks, Stefanie Benoit, Jean A. Yared, Taiga Nishihori, Richard F. Olsson, Cesar O. Freytes, Edward Stadtmauer, Bipin N. Savani, Mohamed L. Sorror, Siddhartha Ganguly, John R. Wingard, Marcelo Pasquini

Research output: Contribution to journalArticlepeer-review

11 Scopus citations


Renal dysfunction is a recognized risk factor for mortality after allogeneic hematopoietic cell transplantation (alloHCT), yet our understanding of the effect of different levels of renal dysfunction at time of transplantation on outcomes remains limited. This study explores the impact of different degrees of renal dysfunction on HCT outcomes and examines whether the utilization of incremental degrees of renal dysfunction based on estimated glomerular filtration rate (eGFR) improve the predictability of the hematopoietic cell transplantation comorbidity index (HCT-CI). The study population included 2 cohorts: cohort 1, comprising patients age ≥40 years who underwent alloHCT for treatment of hematologic malignancies between 2008 and 2016 (n = 13,505; cohort selected given a very low incidence of renal dysfunction in individuals age <40 years), and cohort 2, comprising patients on dialysis at the time of HCT (n = 46). eGFR was measured using the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) method. The patients in cohort 1 were assigned into 4 categories—eGFR ≥90 mL/min (n = 7062), eGFR 60 to 89 mL/min (n = 5264), eGFR 45 to 59 mL/min (n = 897), and eGFR <45 mL/min (n=282)—to assess the impact of degree of renal dysfunction on transplantation outcomes. Transplantation outcomes in patients on dialysis at the time of alloHCT were analyzed separately. eGFR <60 mL/min was associated with an increased risk for nonrelapse mortality (NRM) and requirement for dialysis post-HCT. Compared with the eGFR ≥90 group, the hazard ratio (HR) for NRM was 1.46 (P = .0001) for the eGFR 45 to 59 mL/min group and 1.74 (P = .004) for the eGFR <45 mL/min group. Compared with the eGFR ≥90 mL/min group, the eGFR 45 to 59 mL/min group (HR, 2.45; P < .0001) and the eGFR <45 mL/min group (HR, 3.09; P < .0001) had a higher risk of renal failure necessitating dialysis after alloHCT. In addition, eGFR <45 mL/min was associated with an increased overall mortality (HR, 1.63; P < .0001). An eGFR-based revised HCT-CI was also developed and shown to be predictive of overall survival (OS) and NRM, with predictive performance similar to the original HCT-CI. Among 46 patients on dialysis at alloHCT, the 1-year probability of OS was 20%, and that of NRM was 67%. The degree of pretransplantation renal dysfunction is an independent predictor of OS, NRM, and probability of needing dialysis after alloHCT. An eGFR-based HCT-CI is a validated index for predicting outcomes in adults with hematologic malignancies undergoing alloHCT. The outcomes of alloHCT recipients on dialysis are dismal; therefore, one should strongly weigh the significant risks of being on hemodialysis as a factor in determining alloHCT candidacy.

Original languageEnglish (US)
Pages (from-to)410-422
Number of pages13
JournalTransplantation and Cellular Therapy
Issue number5
StatePublished - May 2021


  • Allogeneic transplantation
  • Dialysis
  • HCT-CI
  • Renal dysfunction
  • Kidney Diseases
  • Hematopoietic Stem Cell Transplantation/adverse effects
  • Hematologic Neoplasms
  • Humans
  • Adult
  • Transplantation, Homologous
  • Renal Dialysis

ASJC Scopus subject areas

  • Transplantation
  • Molecular Medicine
  • Hematology
  • Immunology and Allergy
  • Cell Biology


Dive into the research topics of 'Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell Transplantation: N. Farhadfar et al'. Together they form a unique fingerprint.

Cite this